✦ LIBER ✦

Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease

✍ Scribed by Yu Zhang; Victor O. Ona; Mingwei Li; Martin Drozda; Michel Dubois-Dauphin; Serge Przedborski; Robert J. Ferrante; Robert M. Friedlander

Book ID: 111178139
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 32 KB
Volume: 87
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.2003.02260.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of caspase-1 slows disease pr

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

✍ Friedlander, Robert M.; Ona, Victor O.; Li, Mingwei; Vonsattel, Jean Paul G.; An 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 378 KB

Early and transient alteration of adenos

Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease

✍ Alessia Tarditi; Alessandra Camurri; Katia Varani; Pier Andrea Borea; Ben Woodma 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Striatal atrophy and dendritic alteratio

Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease

✍ Renata P. Lerner; Luz del Carmen G. Trejo Martinez; Chunni Zhu; Marie-Françoise 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 621 KB

Minocycline inhibits caspase-1 and caspa

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

✍ Friedlander, Robert M.; Chen, Minghua; Ona, Victor O.; Li, Mingwei; Ferrante, Ro 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 228 KB

Riluzole prolongs survival time and alte

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease

✍ Johannes Schiefer; G. Bernhard Landwehrmeyer; Hans-Gerd Lüesse; Arne Sprünken; C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of Huntington's disease (HD). Riluzole is a substance with glutamate antagonistic properties that is used for neuroprotective treatment in amyotrophic lateral sclerosis and which is currently tested in clinical trials for

Pharmacologic activation of mitochondria

Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease

✍ Johri, A.; Calingasan, N. Y.; Hennessey, T. M.; Sharma, A.; Yang, L.; Wille, E.; 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 952 KB